Mark Connolly is health economist with over 19 years of experience gained in the pharmaceutical industry, consulting and academia. He has a wide range of pharmaceutical market access, economic modeling and cost-effectiveness experience supporting new product launches and lifecycle management while working in global and regional roles within the pharma industry. His research interests include the economics of healthcare and understanding the broader public economic impact of investments in healthcare applying government perspective frameworks. Dr. Connolly is also the Managing Director and Founder of Global Market Access Solutions with licensed offices in Switzerland, UK and United States. He also holds a guest research position at the University of Groningen Pharmacoeconomics and Pharmacoepidemiology Unit in the Netherlands.